Biomedical Engineering Reference
In-Depth Information
(1st step)
Negishi coupling
OH
OH
O
O
(3rd step)
NC
H
Macrocyclization
H
CO 2 H
Sonogashira
(2nd step)
Borrelidin 161
FIGURE 2.11
Retrosynthetic analysis of borrelidin.
OTBS
OTBS
ZnCl 2 , Et 2 O
then t -BuLi, rt
BnO
BnO
I
Zn
O
O
162
164
7 steps
RO
+
H
OMe
62% (R = Bn)
42% (R = PMB)
58%
OTBS
OTBS
Pd(PPh 3 ) 4 (5 mol%)
dark, rt
I
PMBO
OTBS
OPMB
OBn 165
SCHEME 2.41 Construction of the northern fragment of borrelidin 161 via a modified
Negishi cross-coupling.
163
asymmetric reductive aldol reaction between the suitable protected aldehyde and the
methylacrylate (Scheme 2.41). The alkyl iodide 162 was thus converted to the
corresponding dialkylzinc reagent
164
to afford the advanced precursor
165
in which
all the stereogenic centers were preserved.
2.2.4. Synthesis of Small Heterocycles
2.2.4.1. Brevisamide Brevisamide
is a cyclic ether recently isolated from
the red tide dinoflagellate Karenia brevis [88]. Although it belongs to the same family
of the brevetoxins that are known for their neurotoxic activity, its biological properties
still remain unknown (Figure 2.12).
The convergent approach to the total synthesis of brevisamide
166
166
is based
on the construction of the advanced tetrahydropyrane intermediate
169
starting from
( Z )- anti -crotylsilane
2]-annulation, a
diastereoselective hydroboration, and a hydrozirconation. The side chain presents
a conjugated trisubstituted ( E , E )-diene, introduced through a modified Negishi
167
and aldehyde
168
and features a [4
รพ
Negishi coupling
OH
N
H
O
O
O
Brevisamide 166
FIGURE 2.12
Retrosynthetic analysis of brevisamide.
Search WWH ::




Custom Search